- For Career: +91-7807836763
- For Business : +91-7807096339
- E-mail : biozenta@gmail.com
Biozenta is the vertically integrated, one of the leading and fastest growing pharmaceutical and life sciences group of companies with its presence in various therapies like Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).
Biozenta, a very versatile, fast growing and dynamic organization, established in the year 2018 with a major emphasis to serve the humanity through quality medicines to live the vision “Human helping Human”
Firm believer in Research and Innovation, Biozenta has focused on very unique and innovative products in across the healthcare range. With the state-of-the-art multi-locational EU-GMP approvable facilities, WHO GMP and PICs approved, located in one of the strategic Pharmaceutical Industrial zone of UNA District of H.P., having ultra-modern and well-equipped infrastructure for various units as below:
First
Milestone
Biozenta registered its company in Roorkee, Uttarakhand.
Second
Milestone
Started its Oncology and Critical Care manufacturing Unit at UNA, H.P.
Third
Milestone
Started manufacturing unit for General range Plant for Injectables, Lyophilized Injectables, PFS, Contrast Media and Oral Solids at UNA H.P.
Fourth
Milestone
Established, "Biogracea Medicare", a c-GMP compliant manufacturing unit for “External Preparation Drugs and Cosmetics” at UNA, H. P.
Fifth
Milestone
Started its unique RandD Lab with advanced technology for “MAB-development” (Monoclonal antibody) in Chandigarh.
Sixth
Milestone
Started its corporate office at Mohali Punjab for Business Development Activities and Regulatory Support.
Seventh
Milestone
Proudly received “PICs” approval for Oncology and General Range manufacturing Unit based at UNA, H.P.
Eighth
Milestone
Inaugurated its new “Corporate office” as “Biozenta House” in Mumbai.
Ninth
Milestone
Signed “Partnership deed with US partner for Biosimilar products” to be launched by 2024.
Tenth
Milestone
"Launching into the Domestic Marketing Division" at Mohali, 2023.
Eleventh
Milestone
Inaugurated its new “Corporate office” as “Biozenta, USA”
Global flagship in manufacturing of critical segments of Oncological injectable preparations like Nano particle drugs, Liposomal preparations, Lyophilised and Prefilled Syringe PFS.
Dr. Deep Narayan Sharma, Founder and Managing Director of Biozenta group of companies is a sound technocrat and young, ambitious and dynamic leader. Completed his masters in pharmacy with MBA in Production Management having vast and sound experience in the field of Pharmaceutical manufacturing industry, is a first-generation entrepreneur of his family with lot of passion, focused approach and deep understanding of Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products with major focus on nano-particles and Liposomal technologies.
With 22+ years of experience in corporate industry at various levels including top management and his passion for Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products, he started his first venture in the year 2011 as Dr. Aarbidee Laboratories and Aarya Healthcare (A Division for Food Products) which has been later merged with Biozenta group in 2018.
Under the guiding principles and leadership of Dr. Deep Narayan Sharma, Biozenta achieved various new milestones and offered many innovative Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products.
Firm believer in hard work, self-belief, “walk the talk”, leading by examples, ambitious, innovative approach, “passion for work” are some of the key success factors which he wants to imbibe by every employee of the organization to achieve company’s vision of “Human Helping Human”
Biozenta pursuing and exporting to over 30+ countries across the continents globally which include Asia, Africa, LATAM, CIS, MENA and Europe. With over 180+ international product registrations (many more are under registrations), Biozenta is emerging as one of the leading and fast growing major Indian pharmaceutical manufacturer and exporter. Biozenta is aggressively participating in all the Govt, MOH and local tenders of pharmaceutical formulations, across the globe.
Biozenta strives to be a world class pharmaceutical manufacturer for the development and providing high quality products with superior performance at affordable price. Biozenta’s formulation development and regulatory teams are focused on developing the latest generics to the global markets, with a commitment for continuous flow of innovative products across the globe, in all the therapeutic categories - Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).
Our Branded and Generic medicines enjoy steady demand in following countries:
(Biozenta Participating in all Events)
| Events | Dates |
|---|---|
| Ghana | 16-18 May 2023 |
| Belarus (Wegworus) | 23-26 May 2023 |
| Uzbekistan (Wegwors) | 7-9 June 2023 |
| CPHI & PMEC (Shanghai) | 19-21 June 2023 |
| IPHEX Hyderabad | 5-7 July 2023 |
| Nigeria (Wegworus) | 18-20 July 2023 |
| CPHI Bangkok, Thailand | 16-18 August 2023 |
| Iran | 27-29 September 2023 |
| CPHI Worldwide (Barcelona) | 24-26 October 2023 |
| CPHI & PMEC India | 28-30 November 2023 |
Phone
